My partner has no family history of Wilson disease — what is the chance our child will get it?

This is one of the most common questions from people with Wilson disease who are thinking about starting a family. The short answer is reassuring: if your partner does not carry an ATP7B gene mutation, your child cannot have Wilson disease. The complication is that roughly 1 in 90 people in the general population carry a single copy of a causative mutation without any symptoms or family history at all.¹ That is why genetic testing — rather than family history alone — is the only reliable way to know where you stand.

How Wilson disease is inherited

Wilson disease is caused by mutations in the ATP7B gene and follows an autosomal recessive inheritance pattern. “Autosomal recessive” means:

• Everyone has two copies of the ATP7B gene — one inherited from each parent.
• Wilson disease only develops when a person inherits two faulty copies, one from each parent.
• A person who inherits just one faulty copy is a carrier: they are almost always completely healthy and usually have no idea.²

If you have Wilson disease, you carry two faulty copies of ATP7B — one on each chromosome. Every child you have will inherit one of your faulty copies. That is unavoidable. The question is what your partner contributes.

Partner’s ATP7B status	Child’s possible outcomes
No mutations (two normal copies)	Every child is a carrier (one faulty copy from you, one normal from partner) — none will develop Wilson disease
Carrier (one faulty copy)	Each child has a 50% chance of being a carrier (healthy) and a 50% chance of having Wilson disease
Has Wilson disease (two faulty copies) — extremely rare scenario	Every child will have Wilson disease

The scenario you are most likely in — where your partner has no known family history — falls into the first or second row. The third row (two affected parents) is theoretically possible but vanishingly rare in practice.

What “no family history” actually tells you

Family history of Wilson disease is not a reliable screening tool, and here is why: because carriers are completely healthy, generations of families can carry the ATP7B mutation without anyone ever developing Wilson disease. A family with zero diagnosed cases can still harbor the mutation — the right two carriers just never had children together before.³

Population genetics studies have estimated that between roughly 1 in 90 and 1 in 100 people in the general population carry at least one disease-causing ATP7B variant.¹ This carrier frequency, combined with standard Mendelian math, produces the widely cited prevalence of Wilson disease of approximately 1 in 30,000 people — though a 2020 analysis of large genomic databases found that the true genetic prevalence may be higher, suggesting that not every person with two mutations actually develops clinically apparent disease (a concept called “incomplete penetrance”).³

What this means practically: your partner’s clean family history is a good sign, but not a guarantee. A family where no one has been diagnosed with Wilson disease could still have an undetected carrier — and genetic testing is the only way to find out.

Should your partner get tested?

This decision is personal, and the right choice depends on how much certainty matters to you both. Here is a framework:

If you want certainty before conceiving: your partner should have genetic testing for ATP7B mutations. This is typically done through a blood sample sent to a specialist genetics or metabolic genetics laboratory. Your hepatologist or a genetic counselor can arrange a referral.

• If your partner tests negative for all tested mutations: the chance of your child having Wilson disease is extremely low — effectively zero for the mutations covered by the test panel. No follow-up is needed for your children.
• If your partner tests positive (carrier): each child has a 1 in 2 chance of having Wilson disease, and your care team will discuss options including prenatal testing or early childhood screening after birth.

If you prefer not to test or testing isn’t immediately accessible: the baseline population risk still applies. Based on a carrier frequency of approximately 1 in 90, the risk that your partner is also a carrier — and that a given child could inherit two faulty copies — is approximately 1 in 180 (one faulty copy from each of two carriers × chance partner is a carrier). This is a low but nonzero risk. ¹³

Important limitation: ATP7B testing panels cover the most common known mutations but do not detect every possible variant. A negative result meaningfully reduces risk but cannot reduce it to absolute zero. A genetic counselor can explain the detection rate of the specific panel used in your region.

What happens if your child is a carrier?

A child who inherits one faulty copy from you and one normal copy from your partner is a carrier — just like many people in the general population. Carriers of Wilson disease are healthy and do not develop the condition.² They will not need treatment or monitoring for Wilson disease. They may want to disclose their carrier status to their own future partners when family planning, but that is a conversation for their adulthood.

Early screening for affected children

If your partner turns out to be a carrier and you conceive, or if you have any uncertainty about your child’s status, early screening is possible and important — because Wilson disease is highly treatable when caught early, before symptoms appear.⁴ Genetic testing of the child can be done after birth. If two disease-causing mutations are found, treatment can begin prophylactically in childhood, preventing the liver and neurological damage that otherwise takes years to accumulate.⁵

The family-screening article covers in detail when and how to screen children, siblings, and other relatives. For children specifically, the decision about when to test typically comes up in early adolescence if not already done — though with a known at-risk child (both parents are carriers or one parent has the disease), testing much earlier is appropriate.

What to discuss with your medical team

Before or early in a planned pregnancy, raise these questions with your hepatologist and, ideally, a genetic counselor:

1. Can my partner have ATP7B carrier testing? Where is it done locally?
2. Which mutation(s) do I carry — and does knowing my specific variants help interpret a negative result in my partner?
3. If we don’t test, what is the recommended approach for screening our child after birth?
4. Is pre-implantation genetic diagnosis (PGD) an option for us if we are using assisted reproduction?

For more context on what to bring to your appointments, see what-to-tell-doctor. For the pregnancy management side of things once you are expecting, pregnancy covers medication safety, monitoring, and delivery planning.

The bottom line

If your partner carries no ATP7B mutations, your child will be a carrier but will not have Wilson disease. That is the most likely outcome. The uncertainty is simply that you can’t confirm your partner is mutation-free without a test — family history alone can miss silent carriers. A conversation with a genetic counselor is the most useful next step, and it is a conversation worth having before conception rather than after.

This article is patient education, not medical advice. Genetic risk calculations depend on your specific mutations, your partner’s test results, and factors your care team will assess individually. Please discuss family planning with your hepatologist and a genetic counselor.

References